サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1422916

関節内補充療法市場：タイプ、年齢層、流通チャネル、用途、最終用途、地域別、2024年～2032年

Viscosupplementation Market by Type, Age Group, Distribution Channel, Application, End Use, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 149 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
関節内補充療法市場：タイプ、年齢層、流通チャネル、用途、最終用途、地域別、2024年～2032年
出版日: 2024年01月30日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

関節内補充療法の世界市場規模は2023年に45億米ドルに達しました。今後、IMARC Groupは、市場が2032年までに87億米ドルに達し、2024～2032年の成長率（CAGR）は7.42％になると予測しています。骨粗鬆症と変形性関節症（OA）の有病率の増加と、低侵襲の非外科的治療に対する消費者の傾向の変化は、市場を牽引する主要な要因のいくつかです。

関節内補充療法は、低侵襲の医療処置であり、外因性水硬性酸（HA）誘導体として知られるゲル状の液体からなる関節内注射が、患者の膝関節に直接投与されます。これは潤滑油として働き、骨が互いにスムーズに動くようにし、炎症を抑え、関節荷重に対するショックアブソーバーとして機能します。関節内補充療法は、動作中の摩擦を減らし、滑液がより多くのクッションを作るのを助け、激しい痛みをなくし、関節の可動域や動きを強化します。これとは別に、滑液のレオロジー特性を回復させ、力学的効果、鎮痛効果、抗炎症効果、軟骨保護効果をもたらします。その結果、関節内補充療法は変形性膝関節症、股関節症、手関節症の治療に広く利用されています。現在、主に中間分子量、低分子量、高分子量のものが販売されています。

関節内補充療法市場の動向：

骨粗鬆症と変形性関節症（OA）の有病率の増加は、市場成長を促進する重要な要因の一つです。これに伴い、低侵襲の非外科的治療法に対する消費者の志向の変化が、副腎皮質ステロイドと関節痛管理のためのヘルスケア分野での関節内補充療法の広範な採用を促進しています。これが、もう一つの大きな成長促進要因となっています。さらに、非外科的治療の利点である、入院が不要、費用が少ない、合併症が少ない、臨床結果と回復率が良い、などに関する消費者の意識が高まっていることも影響しています。さらに、政府の積極的な取り組みや、新薬の上市やさまざまな投与経路への製薬企業による多額の投資が、市場の成長を支えています。さらに、関節、靭帯、筋肉、脊椎、神経など、身体のさまざまな部位の外科的・非外科的問題を解決するための集中治療を提供する外来手術センター（ACS）の出現が、市場の成長を後押ししています。さらに、水圧酸を用いた非盲検単回注射の導入が市場成長を促進しています。これとは別に、有利な医療保険償還政策、慢性疾患にかかりやすい高齢者人口の増加、慢性障害者の増加、主要企業間の協力や提携、医療科学分野における継続的な研究開発（R&D）活動が市場成長にプラスの影響を与えています。

本レポートで扱う主な質問

  • 関節内補充療法の世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 世界の関節内補充療法市場における市場促進要因、抑制要因、機会は何か？
  • 主要な地域市場とは？
  • 最も魅力的な関節内補充療法市場はどの国か？
  • タイプ別の市場内訳は？
  • 年齢層別の市場内訳は？
  • 流通チャネル別の市場内訳は？
  • 用途別の市場内訳は？
  • 最終用途別の市場内訳は？
  • 世界の関節内補充療法市場の競争構造は？
  • 関節内補充療法の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の関節内補充療法市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 単回注射
    • 市場動向
    • 市場予測
  • 3回注射
    • 市場動向
    • 市場予測
  • 5回注射
    • 市場動向
    • 市場予測

第7章 市場内訳：年齢層別

  • 成人
    • 市場動向
    • 市場予測
  • 高齢者
    • 市場動向
    • 市場予測

第8章 市場内訳：流通チャネル別

  • 病院薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測

第9章 市場内訳：用途別

  • 変形性膝関節症
    • 市場動向
    • 市場予測
  • 変形性股関節症
    • 市場動向
    • 市場予測
  • 手の変形性関節症
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：最終用途別

  • 病院
    • 市場動向
    • 市場予測
  • 整形外科クリニック
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第11章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第12章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Anika Therapeutics Inc.
    • Aptissen S.A.
    • Bioventus LLC
    • Ferring Pharmaceuticals
    • Fidia Farmaceutici S.p.A.
    • Johnson & Johnson
    • LG Chem Ltd.
    • OrthogenRx Inc.（Avanos Medical Inc.）
    • Sanofi S.A.
    • Seikagaku Corporation
    • Virchow Biotech Private Limited
    • Zimmer Biomet
    • Zuventus HealthCare Ltd.（Emcure Pharmaceuticals Limited）
図表

List of Figures

  • Figure 1: Global: Viscosupplementation Market: Major Drivers and Challenges
  • Figure 2: Global: Viscosupplementation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Viscosupplementation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Viscosupplementation Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Viscosupplementation Market: Breakup by Age Group (in %), 2023
  • Figure 6: Global: Viscosupplementation Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Viscosupplementation Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Viscosupplementation Market: Breakup by End Use (in %), 2023
  • Figure 9: Global: Viscosupplementation Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Viscosupplementation (Single Injection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Viscosupplementation (Single Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Viscosupplementation (Three Injection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Viscosupplementation (Three Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Viscosupplementation (Five Injection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Viscosupplementation (Five Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Viscosupplementation (Adults) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Viscosupplementation (Adults) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Viscosupplementation (Geriatrics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Viscosupplementation (Geriatrics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Viscosupplementation (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Viscosupplementation (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Viscosupplementation (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Viscosupplementation (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Viscosupplementation (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Viscosupplementation (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Viscosupplementation (Knee Osteoarthritis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Viscosupplementation (Knee Osteoarthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Viscosupplementation (Hip Osteoarthritis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Viscosupplementation (Hip Osteoarthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Viscosupplementation (Hand Osteoarthritis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Viscosupplementation (Hand Osteoarthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Viscosupplementation (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Viscosupplementation (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Viscosupplementation (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Viscosupplementation (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Viscosupplementation (Orthopedic Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Viscosupplementation (Orthopedic Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Viscosupplementation (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Viscosupplementation (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Viscosupplementation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Viscosupplementation Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Viscosupplementation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Viscosupplementation Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Viscosupplementation Industry: Value Chain Analysis
  • Figure 91: Global: Viscosupplementation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Viscosupplementation Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Viscosupplementation Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Viscosupplementation Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
  • Table 4: Global: Viscosupplementation Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Viscosupplementation Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Viscosupplementation Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 7: Global: Viscosupplementation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Viscosupplementation Market: Competitive Structure
  • Table 9: Global: Viscosupplementation Market: Key Players
目次
Product Code: SR112024A6931

Abstract

The global viscosupplementation market size reached US$ 4.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.42% during 2024-2032. The increasing prevalence of osteoporosis and osteoarthritis (OA) and the shifting consumer inclination toward minimally invasive non-surgical treatments represent some of the key factors driving the market.

Viscosupplementation represents a minimally invasive medical procedure wherein intraarticular injection comprising gel-like fluid known as exogenous hydraulic acid (HA) derivatives are directly administered into the knee joints of the patient. It acts as a lubricant, which enables bones to move smoothly over each other, lowers inflammation, and performs as a shock absorber for joint loads. Viscosupplementation reduces the friction during the movements, assists the synovial fluids in creating more cushion, eliminates severe pain, and enhances the range of movements or motions of the joint. Apart from this, it restores the rheological properties of the synovial fluids, which produce mechanical, analgesic, anti-inflammatory, and chondroprotective effects. As a result, viscosupplementation is extensively utilized in the treatment of knee, hip, and hand osteoarthritis. Currently, it is mainly available in intermediate, low, and high molecular weights.

Viscosupplementation Market Trends:

The increasing prevalence of osteoporosis and osteoarthritis (OA) represents one of the key factors driving the market growth. In line with this, the shifting consumer inclination toward the minimally invasive non-surgical treatment options has facilitated the widespread adoption of viscosupplementation in the healthcare sector for corticosteroids and joint pain management. This, in turn, is acting as another major growth-inducing factor. This is further influenced by the growing consumer awareness regarding the multiple benefits of non-surgical treatments, including no hospitalization, fewer expenses, minimal complications, and better clinical outcomes and recovery rates. Additionally, the favorable government initiatives and significant investments by various pharmaceutical companies to launch novel drugs and different routes of administrations is supporting the market growth. Moreover, the emergence of ambulatory surgical centers (ACS) that offer intensive treatment to resolve surgical and non-surgical problems in various body parts, such as joints, ligaments, muscle, spine, and nerves, is favoring the market growth. Furthermore, the introduction of open-label single-injections with hydraulic acid is propelling the market growth. Apart from this, favorable health insurance reimbursement policies, the rising geriatric population, which is susceptible to chronic ailments, increasing number of individuals with chronic disability, collaborations and partnership among the key players, and continuous research and development (R&D) activities in the field of medical sciences are positively impacting the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global viscosupplementation market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on type, age group, distribution channel, application and end use.

Type Insights:

Single Injection

Three Injection

Five Injection

The report has also provided a detailed breakup and analysis of viscosupplementation market based on the type. This includes single, three and five injection. According to the report, single injection represented the largest segment.

Age Group Insights:

Adults

Geriatrics

A detailed breakup and analysis of the viscosupplementation market based on the age group has also been provided in the report. This includes adults and geriatric. According to the report, geriatrics accounted for the largest market share.

Distribution Channel Insights:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

The report has also provided a detailed breakup and analysis of viscosupplementation market based on the distribution channel. This includes hospital, retail and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Application Insights:

Knee Osteoarthritis

Hip Osteoarthritis

Hand Osteoarthritis

Others

A detailed breakup and analysis of the viscosupplementation market based on the application has also been provided in the report. This includes knee, hip and hand osteoarthritis. According to the report, knee osteoarthritis accounted for the largest market share.

End Use Insights:

Hospitals

Orthopedic Clinics

Others

The report has also provided a detailed breakup and analysis of viscosupplementation market based on the end use. This includes hospitals, orthopedic clinics, and others. According to the report, orthopedic clinics represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, the North America was the largest market for viscosupplementation. Some of the factors driving the North America viscosupplementation market included the rising geriatric population and the affordable health insurance reimbursement policies.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global viscosupplementation market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Anika Therapeutics Inc., Aptissen S.A., Bioventus LLC, Ferring Pharmaceuticals, Fidia Farmaceutici S.p.A., Johnson & Johnson, LG Chem Ltd., OrthogenRx Inc. (Avanos Medical Inc.), Sanofi S.A., Seikagaku Corporation, Virchow Biotech Private Limited, Zimmer Biomet, Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited), etc.

Key Questions Answered in This Report:

  • How has the global viscosupplementation market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global viscosupplementation market?
  • What are the key regional markets?
  • Which countries represent the most attractive viscosupplementation markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the age group?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What is the competitive structure of the global viscosupplementation market?
  • Who are the key players/companies in the global viscosupplementation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Viscosupplementation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Single Injection
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Three Injection
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Five Injection
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 Adults
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Geriatrics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Knee Osteoarthritis
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hip Osteoarthritis
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Hand Osteoarthritis
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by End Use

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Orthopedic Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Anika Therapeutics Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Aptissen S.A.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Bioventus LLC
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Ferring Pharmaceuticals
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Fidia Farmaceutici S.p.A.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Johnson & Johnson
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 LG Chem Ltd.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 OrthogenRx Inc. (Avanos Medical Inc.)
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Sanofi S.A.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Seikagaku Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Virchow Biotech Private Limited
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Zimmer Biomet
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited)
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio